Alzheimer Disease Test Articles & Analysis: Older
5 news found
The research will serve as the backbone for new augmented reality tools to help at-risk individuals gain timely and accurate health insights using GN Group’s device technologies and, ultimately, to enable early detection of neurodegenerative diseases such as MCI and Alzheimer’s Disease. Altoida’s technology uses artificial ...
Four separate research reports presented at premier Alzheimer’s disease and aging conferences add to the increasing set of details about the accuracy and clinical usefulness of the PrecivityAD™ blood test from C2N Diagnostics. ...
The test helps physicians determine the presence or absence of amyloid plaques in the brain, a hallmark sign of Alzheimer’s disease. “Alzheimer’s is one of the most prevalent and costly diseases in America, with someone newly diagnosed every 60 seconds,” says U.S. ...
Optos Plc, a subsidiary of Nikon Corporation, Japan, and Amydis, Inc. today announced a clinical alliance focused on the development of an eye test by Amydis to detect Alzheimer’s disease. Amydis has developed a pipeline of compounds to detect amyloid proteins in the retina to be visualized with Optos’ market-leading optomap ...
(NYSE: PKI ), a leading provider of drug discovery, life science research, and analytical solutions and Predictive Diagnostics, Inc., a wholly owned subsidiary of Large Scale Biology Corporation (NASDAQ: LSBC), announced today that they have found a series of biomarkers that appear to differ in persons with Alzheimer's Disease compared to persons without ...